Minerva Neurosciences Reports Stock Fluctuations Amid CNS Therapy Developments
Minerva Neurosciences, a biopharmaceutical company, continues to develop innovative treatments for CNS and neuropsychiatric conditions, with its stock price and market capitalization reflecting fluctuations in the biotechnology sector.
2 minutes to read